Citizens Financial Group reported a strong Q1 2026, with a 47% increase in EPS, 7% positive operating leverage, and a 24 basis point NIM expansion. Strategic initiatives like "Reimagine the Bank" and expansion in New York and private banking are progressing well, with a reaffirmed $450 million P&L target by 2028. The company is cautiously optimistic about navigating external challenges and expects favorable outcomes from regulatory changes and stress tests, while maintaining strong loan growth and credit quality.

Royal Caribbean Group has officially launched the Royal Caribbean Group Foundation, formalizing its commitment to global philanthropic partnerships. The Foundation will focus on economic opportunity, community well-being, and environmental stewardship, building on the company's 30-year legacy of investments. Its inaugural pledge supports a new emergency medicine residency program at Jackson Health System in South Florida.

Royal Caribbean Group has established the Royal Caribbean Group Foundation to support global and regional communities through partnerships and community-based solutions, expanding its commitment to strengthening ocean communities. The Foundation will focus on efforts that sustain the planet, energize communities, and accelerate innovation, building on 30 years of the company's investments in education, local economies, and environmental preservation. Its inaugural pledge supports the creation of an Emergency Medicine Residency Program at Jackson Health System in South Florida.

Global food and beverage giants like PepsiCo, Nestlé, and Coca-Cola are significantly increasing their investments in Mexico, recognizing it as a strategic market for both sales and production. Despite attracting billions in investment, the market presents challenges including rising costs, stricter regulations, and intense competition from strong domestic players. Companies are prioritizing efficiency, local sourcing, and supply chain resilience to navigate these complexities and capitalize on Mexico's large consumer market and integration with the US.

Travelers Companies (NYSE: TRV) reported a strong start to 2026 with adjusted earnings per share and revenue beating analyst estimates, driven by a significant surge in core income, higher net investment income, and lower catastrophe losses. Despite overall profit growth and improved combined ratio, the company's Personal Insurance segment saw a 9% decline in net written premiums, reflecting weakness in that area. Travelers also increased its quarterly dividend by 14% and repurchased 6 million shares.

ClaimsFiler is reminding investors of Apollo Global Management, Inc. (NYSE: APO) with losses over $100,000 that they have until May 1, 2026, to file as lead plaintiff in a securities class action lawsuit. The lawsuit alleges that Apollo and its executives made false and misleading statements about the company's business relationship with Jeffrey Epstein, particularly regarding communications between its leaders and Epstein in the 2010s. This alleged entanglement caused significant reputational harm, making the company's public statements about its operations materially false and misleading.

Barclays analysts reacted to reports of Johnson Controls International (JCI) potentially divesting parts of its security business, noting that this development largely aligns with existing investor expectations. The divestment could lead to a 5% adjusted EPS dilution if proceeds are not reinvested, but it could also sharpen JCI's focus on its HVAC and data center businesses. Potential acquirers like Allegion, APi Group, and Honeywell could find these assets earnings-accretive depending on deal structure.

This article covers recent significant business events, including the departure of FedEx CFO John Dietrich and Critical Loop securing $26 million in Series A funding to address power grid bottlenecks. Additionally, Descartes introduced a new AI-driven platform with an agent named "René" to enhance fleet efficiency. These developments highlight major transitions in global logistics, industrial energy, and technological advancements for supply chain optimization.

Kimberly-Clark has announced its post-acquisition leadership structure and key organizational roles, which will take effect following its pending merger with Kenvue Inc. The deal, expected to close in the second half of 2026, will combine prominent brands like Listerine and Band-Aid with Cottonelle, Huggies, and Kleenex. The new entity will feature four business segments, each led by a regional president, while Mike Hsu will continue as chairman and CEO with a direct team reporting to him.

A post-approval study of Medtronic's IN.PACT AV DCB (drug-coated balloon) for end-stage kidney disease patients has demonstrated similar efficacy to its pivotal trial, with 70.2% of lesions remaining open at 12 months without reintervention or thrombosis, compared to 65.3% in the pivotal trial. This outcome addresses long-term safety concerns regarding paclitaxel-coated devices, which previously prompted an FDA requirement for extended monitoring. The FDA had reversed its warning about paclitaxel devices in 2023, indicating no increased risk of death.